DB17368InvestigationalCell transplant therapies
LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.
- Also known as
- mRNA HBV/TCR T-cells
What you can answer from here — as of February 24, 2026
Which companies are running trials of LioCyx-M004, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account